Veracyte, Inc. (VCYT)
40.42
-0.34
(-0.83%)
USD |
NASDAQ |
May 08, 16:00
40.43
+0.01
(+0.02%)
After-Hours: 20:00
Veracyte Research and Development Expense (Annual) : 69.17M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Insight Molecular Diagnostics, Inc. | 14.66M |
| Exagen, Inc. | 6.254M |
| bioAffinity Technologies, Inc. | 2.089M |
| GRAIL, Inc. | 185.38M |
| FONAR Corp. | 1.576M |